Peer-Review Record
Ablative Radiotherapy as a Strategy to Overcome TKI Resistance in EGFR-Mutated NSCLC
Cancers 2022, 14(16), 3983; https://doi.org/10.3390/cancers14163983
by
Jennifer Novak 1, Ravi Salgia 2
, Howard West 2, Miguel A Villalona-Calero 2, Sagus Sampath 1, Terence Williams 1, Victoria Villaflor 2, Erminia Massarelli 2, Ranjan Pathak 2, Marianna Koczywas 2, Brittney Chau 1 and Arya Amini 1,*
, Howard West 2, Miguel A Villalona-Calero 2, Sagus Sampath 1, Terence Williams 1, Victoria Villaflor 2, Erminia Massarelli 2, Ranjan Pathak 2, Marianna Koczywas 2, Brittney Chau 1 and Arya Amini 1,*Reviewer 1:
Anonymous
Reviewer 2:
Anonymous
Cancers 2022, 14(16), 3983; https://doi.org/10.3390/cancers14163983
Submission received: 14 July 2022
/
Revised: 2 August 2022
/
Accepted: 16 August 2022
/
Published: 18 August 2022
(This article belongs to the Special Issue Mechanisms of Resistance in EGFR-Mutated Non-Small Cell Lung Cancer)
Round 1
Reviewer 1 Report
The manuscript is easier to read after the changes made.
Congrats to the authors for the manuscript and persistence required to complete this review.
Minor changes:
In methods, "randomized" appears repeated.
Author Response
the repeated word "randomized" has been removed from the methods section
Reviewer 2 Report
The comments raised by the previous reviewer were responded well.
Author Response
Thank you
